Dr. Richard David Schulick, MBA, MD

Dr. Schulick practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Schulick's NPI, 1265465850, was assigned on July 8, 2006. Dr. Schulick graduated from The Johns Hopkins University School of Medicine in 1989. Dr. Schulick holds Colorado license DR.0051066.

Dr. Schulick's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Schulick's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Schulick to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schulick practices. Vendor and product names are available with a free account.

Surgical oncology is Dr. Schulick's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Schulick is board certified in american board of clinical pharmacology by the American Board of Clinical Pharmacology. Dmand AI has Dr. Schulick's licenses on file in 3 states: Colorado, Maryland and New York.

CMS data shows 154 Medicare services from Dr. Schulick across 6 procedure codes in 2024, for 117 Medicare patients. Medicare paid $52,284 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 117 Medicare patients who saw Dr. Schulick in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schulick's median patient age at 73, with 49% women.

In 2024, Dr. Schulick wrote 59 Medicare Part D claims for 25 patients. 59% of them were for generic drugs. CMS names the drug for 21 of them, across 1 drug with 11 or more claims each, at $82,109 in total drug cost. In 2023, CMS named 42 claims across 2 drugs.

Dr. Schulick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 368 papers to Dr. Schulick, published from 2005 to 2025. 2024 was the busiest year, with 22. The most frequent topics are Pancreatic Neoplasms, Adenocarcinoma and Pancreaticoduodenectomy. Dr. Schulick has published most often in Ann Surg Oncol. Dr. Schulick's most frequent co-authors are Marco Del Chiaro, MD, John L. Cameron, MD and Christopher Wolfgang, MD, PhD.

Dmand AI links Dr. Schulick to 2 clinical trials, 2 of them phase 1 studies. Conditions studied include Rectal Neoplasms, Stomach Neoplasms and Colonic Neoplasms.

CMS Open Payments shows 32 general payments to Dr. Schulick from 4 drug and device companies from 2016 to 2025. Education make up the largest share, 73% of the total. Intuitive Surgical, Inc. paid the most, $9,126.

Dmand AI lists 15 awards for Dr. Schulick, most recently 5280 Top Doctors in Denver in 2016.

Dr. Schulick graduated from The Johns Hopkins University School of Medicine in 1989. Dr. Schulick is a member of ACS and Americas Hepato-Pancreato-Biliary Association.

Dr. Schulick is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.